Review: Oral drugs for type 2 diabetes, alone or in combination, have different relative benefits and harms for surrogate endpoints

Research output: Contribution to journal › Comment/debate › peer-review

ASJC Scopus subject areas

@article{d29e06b5fcec436c99087053842b5853,

title = "Review: Oral drugs for type 2 diabetes, alone or in combination, have different relative benefits and harms for surrogate endpoints",

author = "Bennett, {W. L.}",

year = "2011",

month = aug,

day = "16",

doi = "10.7326/0003-4819-155-4-201108160-02004",

language = "English (US)",

volume = "155",

pages = "JC2--JC4",

journal = "Annals of internal medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "4",

}

TY - JOUR

T1 - Review

T2 - Oral drugs for type 2 diabetes, alone or in combination, have different relative benefits and harms for surrogate endpoints

AU - Bennett, W. L.

PY - 2011/8/16

Y1 - 2011/8/16

UR - http://www.scopus.com/inward/record.url?scp=80051636025&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051636025&partnerID=8YFLogxK

U2 - 10.7326/0003-4819-155-4-201108160-02004

DO - 10.7326/0003-4819-155-4-201108160-02004

M3 - Comment/debate

AN - SCOPUS:80051636025

SN - 0003-4819

VL - 155

SP - JC2-JC4

JO - Annals of internal medicine

JF - Annals of internal medicine

IS - 4

ER -